KAISER SUNNYSIDE MEDICAL CENTER
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $3.6M
- Transactions
- 397
- Companies
- 40
- Average per transaction
- $9,004
Who reported the payments
| Sanofi Pasteur Inc. | $779,912 |
| Merck | $769,680 |
| Genentech, Inc. | $553,794 |
| Regeneron | $252,488 |
| Janssen Scientific Affairs, LLC | $189,068 |
| AbbVie | $152,802 |
| Ocular Therapeutix, Inc. | $138,009 |
| Genmab U.S., Inc. | $102,973 |
| Amarin Pharma, Inc. | $100,000 |
| Boehringer Ingelheim | $85,605 |
| Stryker | $70,244 |
| Takeda Pharmaceuticals U.S.A., Inc. | $61,146 |
| Incyte Corporation | $50,600 |
| Janssen Research & Development, LLC | $39,983 |
| E.r. Squibb & Sons, L.L.C. | $36,104 |
| Mayne Pharma Commercial LLC | $30,347 |
| Intercept Pharmaceuticals, Inc. | $29,602 |
| Puma Biotechnology, Inc. | $25,964 |
| ADC Therapeutics America, Inc. | $23,211 |
| Masimo Corporation | $20,423 |
| Medtronic | $9,037 |
| Gyrus ACMI, Inc. | $8,266 |
| Jazz Pharmaceuticals Inc. | $6,500 |
| EMD Serono, Inc. | $5,409 |
| Pharmacyclics LLC, An Abbvie Company | $4,456 |
| Linvatec Corporation | $4,347 |
| Edwards Lifesciences | $4,300 |
| Oticon Medical, LLC | $3,787 |
| Ares Trading SA | $3,300 |
| Karyopharm Therapeutics Inc. | $2,676 |
| Endotronix, Inc. | $2,400 |
| Spiration, Inc. | $2,400 |
| Vivus LLC | $1,520 |
| Biotronik Inc. | $1,443 |
| Boston Scientific | $1,364 |
| Eisai Inc. | $667 |
| Endologix LLC | $520 |
| Cochlear Americas | $273 |
| Zimmer Biomet | $81 |
| Vero Biotech Inc. | $78 |